Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Eiger BioPharmaceuticals, Inc.Listing unverified | Buy | $21.8K | conv 54ClusterFirst in 12mo | SEC | |
Eiger BioPharmaceuticals, Inc.Listing unverified | Buy | $3M | conv 54ClusterFirst in 12mo | SEC | |
Sagent Pharmaceuticals, Inc.Listing unverified | Sell | $60.2K | SEC | ||
Sagent Pharmaceuticals, Inc.Listing unverified | Sell | $11.5K | SEC | ||
Sagent Pharmaceuticals, Inc.Listing unverified | Sell | $1.6M | Unusual size | SEC | |
Sagent Pharmaceuticals, Inc.Listing unverified | Sell | $8.2M | Unusual size | SEC | |
Sagent Pharmaceuticals, Inc.Listing unverified | Sell | $1.1M | SEC | ||
Sagent Pharmaceuticals, Inc.Listing unverified | Sell | $8K | SEC | ||
AVANIR PHARMACEUTICALS, INC.Listing unverified | Sell | $331.7K | SEC | ||
AVANIR PHARMACEUTICALS, INC.Listing unverified | Sell | $326K | SEC | ||
AVANIR PHARMACEUTICALS, INC.Listing unverified | Sell | $295.5K | SEC | ||
AVANIR PHARMACEUTICALS, INC.Listing unverified | Sell | $3.1K | Unusual size | SEC |